Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - YUMANITY THERAPEUTICS, INC. | d51046dex321.htm |
| EX-31.2 - EX-31.2 - YUMANITY THERAPEUTICS, INC. | d51046dex312.htm |
| EX-31.1 - EX-31.1 - YUMANITY THERAPEUTICS, INC. | d51046dex311.htm |
| EX-21.1 - EX-21.1 - YUMANITY THERAPEUTICS, INC. | d51046dex211.htm |
| EX-10.14 - EX-10.14 - YUMANITY THERAPEUTICS, INC. | d51046dex1014.htm |
| EX-4.2 - EX-4.2 - YUMANITY THERAPEUTICS, INC. | d51046dex42.htm |
| 10-K - 10-K - YUMANITY THERAPEUTICS, INC. | d51046d10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-252695, 333-224180 and 333-228529) and Form S-8 (Nos. 333-252692, 333-252691, 333-237181, 333-230155, 333-223664, 333-218544 and 333-210521) of Yumanity Therapeutics, Inc. of our report dated March 31, 2021 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 31, 2021